ID   CGBC 02
AC   CVCL_VG72
SY   CGBC02; Chang-Gung Breast Cancer 02
DR   Wikidata; Q54811577
RX   PubMed=29484537;
CC   Population: Chinese; Han in Taiwan.
CC   Characteristics: ER/PR-positive and ERBB2-negative.
CC   Doubling time: 52.34 hours (PubMed=29484537).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=29484537
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 13,15
ST   D19S433: 13.2,15.2
ST   D21S11: 29,31
ST   D2S1338: 17,22
ST   D3S1358: 16,17
ST   D5S818: 9,13
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
RX   PubMed=29484537; DOI=10.1007/s13577-017-0197-3; PMCID=PMC5852199;
RA   Kuo W.-L., Ueng S.-H., Wu C.-H., Lee L.-Y., Lee Y.-S., Yu M.-C.,
RA   Chen S.-C., Yu C.-C., Tsai C.-N.;
RT   "Establishment of two basal-like breast cancer cell lines with
RT   extremely low tumorigenicity from Taiwanese premenopausal women.";
RL   Hum. Cell 31:154-166(2018).
//